Jessica R Gilbert1, Jessica L Gerner2, Courtney R Burton2, Allison C Nugent3, Carlos A Zarate2, Elizabeth D Ballard2. 1. Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA. Electronic address: jessica.gilbert@nih.gov. 2. Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA. 3. MEG Core Facility, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
Abstract
BACKGROUND: This study examined magnetoencephalographic (MEG) correlates of suicidal ideation (SI) and suicide attempt history in patients with treatment-resistant major depression (TRD) at baseline and following subanesthetic-dose ketamine infusion. METHODS: Twenty-nine drug-free TRD patients (12 suicide attempters/17 non-attempters) participated in a crossover randomized trial of ketamine. MEG data were collected during an attentional dot probe task with emotional face stimuli at baseline and several hours post-ketamine infusion. Synthetic aperture magnetometry was used to project source power in the theta, alpha, beta, and gamma frequencies for angry-neutral, happy-neutral, and neutral-neutral face pairings during a one-second peristimulus period. Mixed models were used to test for clinical, behavioral, and electrophysiological effects of group, emotion, session, and SI score. RESULTS: Ketamine significantly reduced SI and depression across the sample. Post-ketamine, attempters had improved accuracy and non-attempters had reduced accuracy on the task. SI was positively associated with gamma power in regions of the frontal and parietal cortices across groups. In an extended amygdala-hippocampal region, attempters differed significantly in their emotional reactivity to angry versus happy faces as indexed by theta power differences, irrespective of drug. Ketamine significantly reduced the association between alpha power and SI for angry compared with happy faces in a fronto-insular/anterior cingulate region important for regulating sensory attentiveness. LIMITATIONS: Limitations include a small sample size of attempters. CONCLUSIONS: The findings highlight key differences in band-limited power between attempters and non-attempters and reinforce previous findings that ketamine has distinct response properties in patients with a suicide history. Published by Elsevier B.V.
BACKGROUND: This study examined magnetoencephalographic (MEG) correlates of suicidal ideation (SI) and suicide attempt history in patients with treatment-resistant major depression (TRD) at baseline and following subanesthetic-dose ketamine infusion. METHODS: Twenty-nine drug-free TRD patients (12 suicide attempters/17 non-attempters) participated in a crossover randomized trial of ketamine. MEG data were collected during an attentional dot probe task with emotional face stimuli at baseline and several hours post-ketamine infusion. Synthetic aperture magnetometry was used to project source power in the theta, alpha, beta, and gamma frequencies for angry-neutral, happy-neutral, and neutral-neutral face pairings during a one-second peristimulus period. Mixed models were used to test for clinical, behavioral, and electrophysiological effects of group, emotion, session, and SI score. RESULTS: Ketamine significantly reduced SI and depression across the sample. Post-ketamine, attempters had improved accuracy and non-attempters had reduced accuracy on the task. SI was positively associated with gamma power in regions of the frontal and parietal cortices across groups. In an extended amygdala-hippocampal region, attempters differed significantly in their emotional reactivity to angry versus happy faces as indexed by theta power differences, irrespective of drug. Ketamine significantly reduced the association between alpha power and SI for angry compared with happy faces in a fronto-insular/anterior cingulate region important for regulating sensory attentiveness. LIMITATIONS: Limitations include a small sample size of attempters. CONCLUSIONS: The findings highlight key differences in band-limited power between attempters and non-attempters and reinforce previous findings that ketamine has distinct response properties in patients with a suicide history. Published by Elsevier B.V.
Authors: Jessica R Gilbert; Elizabeth D Ballard; Christina S Galiano; Allison C Nugent; Carlos A Zarate Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2019-12-03
Authors: Elizabeth D Ballard; Julia S Yarrington; Cristan A Farmer; Marc S Lener; Bashkim Kadriu; Níall Lally; Deonte Williams; Rodrigo Machado-Vieira; Mark J Niciu; Lawrence Park; Carlos A Zarate Journal: J Affect Disord Date: 2018-02-05 Impact factor: 4.839
Authors: Giacomo Salvadore; Brian R Cornwell; Veronica Colon-Rosario; Richard Coppola; Christian Grillon; Carlos A Zarate; Husseini K Manji Journal: Biol Psychiatry Date: 2008-09-25 Impact factor: 13.382
Authors: Elizabeth D Ballard; Dawn F Ionescu; Jennifer L Vande Voort; Mark J Niciu; Erica M Richards; David A Luckenbaugh; Nancy E Brutsché; Rezvan Ameli; Maura L Furey; Carlos A Zarate Journal: J Psychiatr Res Date: 2014-08-12 Impact factor: 4.791
Authors: Jörg Lesting; Rajeevan T Narayanan; Christian Kluge; Susan Sangha; Thomas Seidenbecher; Hans-Christian Pape Journal: PLoS One Date: 2011-06-28 Impact factor: 3.240
Authors: Allison C Nugent; Elizabeth D Ballard; Jessica R Gilbert; Prejaas K Tewarie; Matthew J Brookes; Carlos A Zarate Journal: Neuroimage Clin Date: 2020-08-08 Impact factor: 4.881